We developed this life sciences marketing maturity model for life sciences companies looking to compare their digital marketing strategy, capabilities, ...

Life sciences marketing companies often lack the necessary tools to create personalized and targeted campaigns. Compliance and regulation often overshadow ...

The global market for personalized medicine is expected to reach $3.18 trillion within the next five years. While cell and gene therapy models present countless advantages for life ...

As businesses scrambled to move operations into the virtual office at the onset of the global COVID-19 pandemic, life sciences ...

Biotech companies are seeking new avenues for Alzheimer’s research after continued failures of several major treatment opportunities in the pipeline. ...

Investments in new microbiome therapies as medicinal products continue to be on the rise and are attracting large Consumer Health ...

Many pharma and biotech businesses implement lean Six Sigma (LSS) practices to lower their operational costs and provide high quality ...

The value that comes from patient journey mapping exercises is well-established in the life sciences industry. These activities are focused ...

The predominate focus of an early stage life sciences on their path to commercialization is on two fronts. The first ...

With a slow, long, and regulated road to successful drug development, along with standard approval gates required for progression, the ...

Defining how your sales force will be organized is a critical task leading up to new pre-commercial product launch. Traditionally, ...

With much of the world focused on the response to COVID-19, many biopharmaceuticals are looking at new ways that they ...